Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

The Diffusion of Acamprosate for the Treatment of Alcohol Use Disorder: Results From a National Longitudinal Study.

Knudsen HK, Roman PM.

J Subst Abuse Treat. 2016 Mar;62:62-7. doi: 10.1016/j.jsat.2015.10.005. Epub 2015 Dec 1.

PMID:
26689318
2.

Rural substance use treatment centers in the United States: an assessment of treatment quality by location.

Bond Edmond M, Aletraris L, Roman PM.

Am J Drug Alcohol Abuse. 2015;41(5):449-57. doi: 10.3109/00952990.2015.1059842.

3.

Innovation attributes and adoption decisions: perspectives from leaders of a national sample of addiction treatment organizations.

Knudsen HK, Roman PM.

J Subst Abuse Treat. 2015 Feb;49:1-7. doi: 10.1016/j.jsat.2014.08.003. Epub 2014 Aug 23.

4.
6.
7.
9.

The employment of nurses in publicly funded substance abuse treatment programs.

Knudsen HK, Abraham AJ.

J Addict Nurs. 2012 Oct;23(3):174-80. doi: 10.1097/JAN.0b013e31826f4c25.

10.

Adoption of evidence-based clinical innovations: the case of buprenorphine use by opioid treatment programs.

Andrews CM, D'Aunno TA, Pollack HA, Friedmann PD.

Med Care Res Rev. 2014 Feb;71(1):43-60. doi: 10.1177/1077558713503188. Epub 2013 Sep 18.

12.

Financial factors and the implementation of medications for treating opioid use disorders.

Knudsen HK, Roman PM.

J Addict Med. 2012 Dec;6(4):280-6. doi: 10.1097/ADM.0b013e318262a97a.

13.

Patient characteristics and availability of onsite non-rapid and rapid HIV testing in US substance use disorder treatment programs.

Abraham AJ, O'Brien LA, Knudsen HK, Bride BE, Smith GR, Roman PM.

J Subst Abuse Treat. 2013 Jan;44(1):120-5. doi: 10.1016/j.jsat.2012.03.004. Epub 2012 Apr 25.

14.

Physicians in the substance abuse treatment workforce: understanding their employment within publicly funded treatment organizations.

Knudsen HK, Oser CB, Abraham AJ, Roman PM.

J Subst Abuse Treat. 2012 Sep;43(2):152-60. doi: 10.1016/j.jsat.2011.12.003. Epub 2012 Feb 1.

15.

Perceptions of the state policy environment and adoption of medications in the treatment of substance use disorders.

Knudsen HK, Abraham AJ.

Psychiatr Serv. 2012 Jan;63(1):19-25. doi: 10.1176/appi.ps.201100034.

16.

Barriers to use of pharmacotherapy for addiction disorders and how to overcome them.

Oliva EM, Maisel NC, Gordon AJ, Harris AH.

Curr Psychiatry Rep. 2011 Oct;13(5):374-81. doi: 10.1007/s11920-011-0222-2. Review.

18.

Using medication-assisted treatment for substance use disorders: evidence of barriers and facilitators of implementation.

Roman PM, Abraham AJ, Knudsen HK.

Addict Behav. 2011 Jun;36(6):584-9. doi: 10.1016/j.addbeh.2011.01.032. Epub 2011 Jan 27.

19.

Barriers to the implementation of medication-assisted treatment for substance use disorders: the importance of funding policies and medical infrastructure.

Knudsen HK, Abraham AJ, Oser CB.

Eval Program Plann. 2011 Nov;34(4):375-81. doi: 10.1016/j.evalprogplan.2011.02.004. Epub 2011 Mar 2.

20.

Nurse turnover in substance abuse treatment programs affiliated with the National Drug Abuse Treatment Clinical Trials Network.

Knudsen HK, Abraham AJ, Roman PM, Studts JL.

J Subst Abuse Treat. 2011 Apr;40(3):307-12. doi: 10.1016/j.jsat.2010.11.012. Epub 2010 Dec 21.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk